| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Veterans Affairs Medical Center of San Diego and Department of Anesthesiology; 2 Department of Molecular Pathology; 3 Department of Medicine and Institute for Molecular Medicine, and 4 Department of Family and Preventative Medicine, University of California, San Diego, California 92161
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Anesthetics provide sedation and immobility facilitating echocardiography in mice, but influence cardiac function. We studied the effects of intraperitoneal and inhaled anesthetic agents on echocardiographic measurements. Mice were anesthetized with intraperitoneal tribromoethanol (TBE), ketamine-midazolam (K/M), ketamine-xylazine (K/X), or inhaled isoflurane (Isf), and echocardiographic parameters were assessed at 5, 10, 15, and 20 min. In C57BL/6N mice, Isf produced high initial heart rates (HR) that decreased to levels comparable to TBE at 15-20 min (~450 beats/min) and the most stable percent fractional shortening (%FS) and end-diastolic dimension (EDD). With TBE, %FS initially was low, but increased comparable to Isf (~45%) at 15 min. K/M produced similar time trends but lower absolute values compared with TBE for all parameters. K/X produced cardiac depression evidenced by low HR and %FS, and increased EDD. Isf was the most reproducible in repeat studies at 12 days. In C57BL/6J compared with C57BL/6N mice, K/M produced higher HR, and %FS and TBE produced smaller EDD. In conclusion, anesthetic agent, timing of echocardiographic measurements, and genetic background are all critical variables during echocardiography in mice.
left ventricular function; tribromoethanol; ketamine; midazolam; xylazine; isoflurane
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
TRANSTHORACIC ECHOCARDIOGRAPHY is a valuable and widely applied tool for the noninvasive serial assessment of cardiac function in mice (8). Given the increasing numbers of transgenic and surgical models of cardiovascular disease in the mouse, echocardiography has become a standard approach for defining cardiac phenotypes and screening transgenic mouse colonies (20). Anesthesia provides sedation and immobility of animals during echocardiography greatly facilitating reliable data acquisition, but it is well recognized to have significant effects on cardiovascular function (22). Various anesthetic agents have been used to achieve sedation for echocardiography in mice, including intraperitoneal injection of ketamine and xylazine (K/X) (20), tribromoethanol (TBE; Avertin) (18), chloral hydrate (20), barbiturates [pentobarbital (26), thiobutabarbital (15)], or inhalation of volatile anesthetics such as isoflurane (Isf) (3, 19) or halothane (5). These agents have diverse pharmacological profiles and produce multiple and variable cardiovascular effects in animals (1, 7). Despite the importance of anesthetic effects on cardiac function, few studies (2, 10, 19, 26) have been published concerning anesthesia during echocardiography in mice. No studies have compared the temporal response of echocardiographic measurements with the use of intraperitoneal and inhaled anesthetics. In addition, although anesthetic effects of barbiturates (9, 11), benzodiazepines (9), and volatile anesthetics (17) vary among mouse strains, only one study (10), which evaluated only TBE, has compared anesthesia in different mouse strains during echocardiography.
Accordingly, the present study was designed to examine the time course of intraperitoneal and volatile anesthetic effects on cardiac function. The reproducibility of each anesthetic agent was assessed by the performance of repeat echocardiographic measurements after 12 days, and the cardiac effects of intraperitoneal and volatile anesthetics were compared in two strains of the commonly used C57BL/6 mouse.
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Experimental animals. Animals were handled according to National Institutes of Health and institutional animal care and use committee guidelines of the University of California- San Diego. Male C57BL/6NCrlBR (C57BL/6N) or C57BL/6J mice (8-10 wk) were obtained from Charles River Laboratories (Wilmington, MA) and Jackson Laboratory (Bar Harbor, ME), respectively.
Experimental protocols. Groups of eight C57BL/6N mice were anesthetized with intraperitoneal TBE, ketamine-midazolam (K/M), K/X, or inhaled Isf. In addition, groups of eight C57BL/6J mice were anesthetized with TBE, K/M, and Isf. Heart rate (HR), left ventricular (LV) fractional shortening (%FS), LV end-diastolic dimension (EDD), and aortic ejection time (C57BL/6N group only) were assessed in all mice with the use of an echocardiograph (Sonos 5500, Agilent) and L15/6-MHz transducer. With mice in the left lateral decubitus position, a parasternal short-axis view was obtained for LV M-mode imaging at the papillary muscle level and LV chamber dimensions were determined.
Echocardiographic measurements were performed by a single blinded observer (N. D. Dalton) at 5, 10, 15, and 20 min after the induction of anesthesia. The intraobserver variability of this observer has been reported previously (20) and is 0.9 ± 8.2% (means ± 2 SD) (n = 12) for LV chamber diameter measurements in C57BL/6 mice. Time to loss and restoration of the righting reflex also were determined for each anesthetic agent. The study was repeated in C57BL/6N mice after 12 days to assess reproducibility of echocardiographic parameters with each anesthetic. One C57BL/6N mouse in the TBE group died in its cage between the first and second anesthetic trial.Anesthetics. Anesthesia was induced by intraperitoneal injection of TBE (12 µl/g of 2.5% solution), ketamine (50 µg/g) and midazolam (3 µg/g), and ketamine (100 µg/g) and xylazine (5 µg/g). Isf anesthesia was administered with the use of a vaporizer (model 100-F, Ohio Medical Instruments). Isf induction was performed by the same individual over a 1-min period in an isolation chamber with 5.0% Isf in 100% O2, and anesthesia was maintained during spontaneous breathing of 1.25% Isf in 100% O2 at a flow rate of 1 l/min via a small nose cone. A small plastic bag surrounding the nose cone was attached to wall suction and scavenged excess gas. All mice within each anesthetic group were studied at the same time of day within a 6-h period of time.
Body and heart weight comparison. Before each study, individual mice were weighed to ensure that mice of similar age and body weight were used and to calculate proper anesthetic dosage in each treatment group. All mice were euthanized 1 mo after the study was completed to assess differences in cardiac size and body weight between experimental groups. After the mice were euthanized, the hearts were removed for morphometric comparison of whole heart weight.
Statistical analysis. For the C57BL/6N mice, a repeated-measures analysis of variance was applied to the various echocardiographic measures, testing for interactions between anesthetic (TBE, K/M, K/X, and Isf) and the time course (5, 10, 15, and 20 min, respectively) and between anesthetic with time course for the two trials (three-way interaction) (24). Significant interactions would indicate that different anesthetics showed a different time course or that the time course differed in reproducibility for anesthetics over the two trials. A similar analysis examined time to loss of righting reflex and duration of loss of the reflex for an interaction between anesthetic and trial.
To compare the two strains of mice, C57BL/6N and C57BL/6J, another repeated-measures analysis of variance study used three anesthetics (TBE, K/M, and Isf) and examined interactions among the following: 1) mouse strain and anesthetic, 2) mouse strain, anesthetic, and time course, and 3) among mouse strain, anesthetics, time course, and trial. However, to illustrate differences between mouse strains, only values at 15 min, generally the time of maximum cardiac effect and adequate reproducibility, are shown. In RESULTS, a statement pointing out significant differences reflects a statistically significant interaction (P < 0.05) for the interaction effect being described. When interactions were significant, a limited number of modified tests with Bonferroni's correction for multiple comparisons were carried out to establish differences between anesthetics (23). All analyses were carried out with the use of Statistical Analysis Software (SAS) (16). Data are represented as means ± SE.| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Time trends for anesthetic agents.
The effects of anesthetics on echocardiographic measurements
in C57BL/6N mice over the 20-min study are shown in Fig.
1. Mice anesthetized with TBE showed a
minimal increase in HR over time. However, TBE produced a large
increase in %FS from a decreased level to a stable normal level
(~45%) at 15 min and a moderate decrease in EDD over time. M-mode
echocardiographic images provided in Fig.
2 illustrate the changes in cardiac
function over time with TBE. Mice anesthetized with K/M showed gradual
increases in HR and %FS to levels less than those with TBE at
15-20 min, but no changes were noted in EDD over time. The
greatest cardiac depression was observed during anesthesia with K/X; HR
was low initially and continued to slow, and the slow HRs coincided
with reduced %FS and enlarged EDD values compared with the other
anesthetic agents. Isf produced the highest HRs and the greatest
stability in %FS over the 20-min study. HR and %FS were comparable
for Isf and TBE at the 15-min time point. Aortic ejection time
increased dramatically over the 20-min study in the K/X group but was
relatively stable over time for the other anesthetics These data
indicate that the anesthetic agent and the time after induction of
anesthesia directly affect echocardiographic measurements.
|
|
Reproducibility of anesthetic agents.
The effects of TBE, K/M, and Isf on cardiac function in C57BL/6N mice
during repeated echocardiographic examination 12 days apart are shown
in Fig. 3. TBE and K/M showed similar
values for HR, %FS, and EDD at some of the time points for each trial,
but other values were dramatically different, with K/M showing more variability between the two studies at 15-20 min. Isf was the most
reproducible compared with TBE and K/M such that there were no
significant differences in HR, %FS, and EDD between the 2 separate trials. These data support the idea that the volatile anesthetic Isf
provides the greatest reproducibility when anesthetizing mice during
repeat studies.
|
Strain differences and anesthetic agents.
The effects of anesthesia on cardiac function in C57BL/6N and C57BL/6J
strains of mice are presented in Fig. 4.
Fifteen minutes after induction of anesthesia with TBE, no difference
in HR or %FS was noted between the strains; however, EDD was
significantly smaller in C57BL/6J mice compared with C57BL/6N mice
(Fig. 4A). Mice anesthetized with K/M showed significantly
increased HR and %FS values and significantly decreased EDD in
C57BL/6J compared with C57BL/6N mice (Fig. 4B). In contrast,
no difference in HR, %FS or EDD was noted between groups during
anesthesia with Isf (Fig. 4C). These data indicate that the
anesthetic effect on cardiac function may vary with the strain of mouse
studied.
|
Onset and duration of anesthesia.
The onset and duration of anesthesia, assessed by the righting
time, are shown in Table 1. Righting
times between C57BL/6N and C57BL/6J mouse strains showed no
significant difference in the time to loss of righting reflex for any
of the anesthetics used. However, the time to regain righting reflex
was significantly shorter for C57BL/6N mice when anesthetized with TBE
and significantly longer with K/M, demonstrating variability in
anesthetic effect between the two strains. The analysis of anesthetics
within strains TBE, K/M, and K/X produced nearly identical times for
onset of anesthesia for C57BL/6N mice; however, anesthetic duration was markedly increased for K/X. In C57BL/6J mice, there was no difference in time to onset of anesthesia using TBE and K/M; however, anesthesia with TBE produced the longest duration to recovery. Anesthesia with Isf
exhibited the most rapid loss and regaining of righting reflex in
either strain of mouse except for K/M in the C57BL/6J group.
|
Body weight and heart weight. Body weights at the time of echocardiographic measurement and final heart weights for C57BL/6N and C57BL/6J are shown in Table 1. There were no significant differences in initial body weight or final whole heart weight between mice used in the study.
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Our study demonstrates that the type of anesthesia and the timing of echocardiographic measurements after anesthesia can have significant effects on echocardiographic parameters in mice. Reproducibility of echocardiographic measurements twelve days later was not substantially different between anesthetics. Differences in anesthetic effects on righting reflex, HR, and echocardiographic measurements were found between mouse strains.
Comparison of intraperitoneal versus inhaled volatile anesthesia.
Intraperitoneal injection of the dissociative anesthetic ketamine
combined with the 
2-agonist xylazine (K/X) (19,
20, 26) and TBE (6, 12, 18), formerly available
under the trade name Avertin, have been used by many investigators
during echocardiography studies of the mouse. K/X can produce
bradycardia and hypotension in mice (25) and produced the
greatest cardiac depression in our study. Intraperitoneal TBE produces
less hemodynamic compromise in the mouse; however, toxicity and
mortality have been reported (25, 27) that may be
eliminated by proper storage of the drug (4°C and dark conditions)
(14). The benzodiazepine midazolam produces minimal
cardiac depression when used alone (7). Midazolam combined
with ketamine in our study produced less cardiac depression than K/X
but greater cardiac depression than TBE. All intraperitoneal agents
showed early depression of cardiac function and exhibited an increase
in %FS over the 20-min study. All intraperitoneal agents except K/X
were associated with increasing HR.
Timing of measurements. A novel finding of our study was the significant variability of echocardiographic measurements over time after induction of anesthesia. This finding was most striking for the intraperitoneal anesthetics. Most studies do not report the time after anesthesia that echocardiographic images are acquired. However, it is clear from our study that time is a critical variable. Time of measurements should be controlled for and reported in investigations to allow for comparison of cardiac function between experimental groups in a single study and between studies by different investigators.
Animal strain. The anesthetic effects of barbiturates, benzodiazepines, and volatile anesthetics vary among mouse strains (9, 11, 17). Kiatchoosakun et al. (10) compared TBE anesthesia during echocardiography in three mouse strains and found differences in LV EDDs between C57BL/6J and A/J mice but concluded that the degree of cardiac depression resulting from TBE anesthesia was statistically similar in C57BL/6J, A/J, and FVB/N strains. Interestingly, despite comparing two closely related strains of C57BL/6 mice, we found TBE produced similar HR and %FS values; however, EDD varied significantly between strains. K/M produced significant differences for all cardiac parameters and a doubling in the time to regain righting reflex when the two strains were compared. Variation in sleep time between mouse strains following midazolam may vary >300% (9). These findings may reflect a lighter plane of anesthesia with K/M between C57BL/6J and C57BL/6N mice and subsequently less cardiac depression. Isf produced no differences in any of the cardiac parameters between the two strains. These differences show that one anesthetic agent may not be suitable for all mouse strains and emphasize the need for strain-matched control groups in echocardiographic studies.
Ideal approach to echocardiography in mice. The ideal anesthesia for mouse echocardiography should be easy to administer, reproducible, rapid in onset and recovery, cause minimal HR and cardiac depression, and have low toxicity. Identification of an ideal agent for all studies is difficult, but Isf and TBE came closest to these goals. K/M showed less reproducibility and slower HR and %FS, although values approached normal in one mouse strain (C57BL/6J).
Some suggest echocardiography in conscious mice is preferable to using anesthetics. Yang et al. (26) found significant decreases in HR and cardiac contractility with intraperitoneal pentobarbital sodium or K/X compared with conscious mice. Awake measurements required training sessions to prevent bradycardia during transducer placement and awake heart rates averaged 658 beats/min, a value significantly higher than some HR quoted for unrestrained mice during telemetry (568 beats/min) (21), suggesting the possibility of elevated sympathetic tone during awake measurements. Similar HR and %FS values were reported by Esposito et al. (4) during conscious echocardiography in mice. Kiatchoosakun et al. (10) reported HR of 612, 680, and 732 beats/min in conscious A/J, C57BL/6J, and FVB/N mouse strains, respectively, and were unable to adequately perform Doppler measurements in conscious mice despite training and manual restraint. Takuma et al. (19) found %FS was not different between Isf anesthesia and conscious mice and noted in awake mice variations in probe position may have affected the results. The necessity of training regimens, problems with transducer placement, variations in sympathetic and parasympathetic tone during restraint, and relatively high HR make measurements in conscious mice less than ideal for all applications of echocardiography. Thus an ideal method for echocardiography in mice appears not to be available because studies in conscious mice have higher HR and the best anesthetics produce somewhat lower heart rates than those in unrestrained mice, and HR in mice correlate well with cardiac contractility (13).Choice of anesthetic. We evaluated anesthetics only in mice with normal cardiac function. The "ideal" anesthetic for mice with cardiomyopathy may differ depending on the study goals, the type and extent of cardiomyopathy, and the strain of mouse. For example, anesthetics with less cardiac depression such as Isf and TBE (or perhaps conscious measurements) may be used to establish whether or not cardiac function and morphology are normal in transgenic or knockout mice. Isf or TBE would be the anesthetic of choice if cardiac function were known to be depressed. If repeated or prolonged studies were needed under stable conditions in a single study, Isf would clearly be preferable. On the other hand, K/X may be advantageous to reduce HR and cardiac contractility in evaluating echocardiographic and Doppler measurements in models of hypertrophic cardiomyopathy, in which there is hyperfunction and impaired cardiac relaxation.
Limitations of current study. We examined only one dose of each anesthetic, although doses were selected to be in agreement with published reports. Given the time constraint of repeat measurements at 5 min, we were able to make only one Doppler measurement (aortic ejection time). Future studies will be necessary to evaluate the full impact of anesthesia on Doppler measurements in mice.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Jeffrey Drumm and Farid Abdel-Wahaab for technical expertise.
| |
FOOTNOTES |
|---|
D. Roth is supported by an Advanced Research Career Development Award from the Department of Veterans Affairs. This study was supported in part by National Heart, Lung, and Blood Institute Grant HL-46345 and the Richard D. Winter Fund.
Address for reprint requests and other correspondence: D. M. Roth, Veterans Affairs Medical Center, Rm. 125, 3350 La Jolla Village Dr., San Diego, CA 92161 (E-mail: droth{at}ucsd.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpheart.00845.2001
Received 28 September 2001; accepted in final form 17 January 2002.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Brunson, DB.
Pharmacology of inhalational anesthetics.
In: Anesthesia and Analgesia in Laboratory Animals, edited by Kohn DF,
Wixson SK,
White WJ,
and Benson GJ.. New York: Academic, 1997, p. 29-41.
2.
Chaves, AA,
Weinstein DM,
and
Bauer JA.
Non-invasive echocardiographic studies in mice influence of anesthetic regimen.
Life Sci
69:
213-222,
2001[ISI][Medline].
3.
Collins, KA,
Korcarz CE,
Shroff SG,
Bednarz JE,
Fentzke RC,
Lin H,
Leiden JM,
and
Lang RM.
Accuracy of echocardiographic estimates of left ventricular mass in mice.
Am J Physiol Heart Circ Physiol
280:
H1954-H1962,
2001
4.
Esposito, G,
Santana LF,
Dilly K,
Cruz JDS,
Mao L,
Lederer WJ,
and
Rockman HA.
Cellular and functional defects in a mouse model of heart failure.
Am J Physiol Heart Circ Physiol
279:
H3101-H3112,
2000
5.
Fentzke, RC,
Korcarz CE,
Lang RM,
Lin H,
and
Leiden JM.
Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.
J Clin Invest
101:
2415-2426,
1998[ISI][Medline].
6.
Fentzke, RC,
Korcarz CE,
Shroff SG,
Lin H,
Leiden JM,
and
Lang RM.
The left ventricular stress-velocity relation in transgenic mice expressing a dominant negative CREB transgene in the heart.
J Am Soc Echocardiogr
14:
209-218,
2001[ISI][Medline].
7.
Fish, RE.
Pharmacology of injectable anesthetics.
In: Anesthesia and Analgesia in Laboratory Animals, edited by Kohn DF,
Wixson SK,
White WJ,
and Benson GJ.. New York: Academic, 1997, p. 1-28.
8.
Hoit, BD.
New approaches to phenotypic analysis in adult mice.
J Mol Cell Cardiol
33:
27-35,
2001[ISI][Medline].
9.
Homanics, GE,
Quinlan JJ,
and
Firestone LL.
Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines.
Pharmacol Biochem Behav
63:
21-26,
1999[ISI][Medline].
10.
Kiatchoosakun, S,
Kirkpatrick D,
and
Hoit BD.
Effects of tribromoethanol anesthesia on echocardiographic assessment of left ventricular function in mice.
Compar Med
51:
26-29,
2001.
11.
Lovell, DP.
Variation in pentobarbitone sleeping time in mice. 1. Strain and sex differences.
Lab Anim
20:
85-90,
1986
12.
Minamisawa, S,
Hoshijima M,
Chu G,
Ward CA,
Frank K,
Gu Y,
Martone ME,
Wang Y,
Ross J, Jr.,
Kranias EG,
Giles WR,
and
Chien KR.
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
Cell
99:
313-322,
1999[ISI][Medline].
13.
Palakodeti, V,
Oh S,
Oh BH,
Mao L,
Hongo M,
Peterson KL,
and
Ross J, Jr.
Force-frequency effect is a powerful determinant of myocardial contractility in the mouse.
Am J Physiol Heart Circ Physiol
273:
H1283-H1290,
1997
14.
Papaioannou, VE,
and
Fox JG.
Use and efficacy of tribromoethanol anesthesia in the mouse.
Lab Anim Sci
43:
189-192,
1993[ISI][Medline].
15.
Roth, DM,
Gao MH,
Lai NC,
Drumm J,
Dalton N,
Zhou JY,
Zhu J,
Entrikin D,
and
Hammond HK.
Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.
Circulation
99:
3099-3102,
1999
16.
SAS Institute.
SAS/STAT User's Guide. Cary, NC: SAS, 1994, p. 891-996.
17.
Sonner, JM,
Gong D,
Li J,
Eger EI,
and
Laster MJ.
Mouse strain modestly influences minimum alveolar anesthetic concentration and convulsivity of inhaled compounds.
Anesth Analg
89:
1030-1034,
1999
18.
Takeishi, Y,
Ping P,
Bolli R,
Kirkpatrick DL,
Hoit BD,
and
Walsh RA.
Transgenic overexpression of constitutively active protein kinase C
causes concentric cardiac hypertrophy.
Circ Res
86:
1218-1223,
2000
19.
Takuma, S,
Suehiro K,
Cardinale C,
Hozumi T,
Yano H,
Shimizu J,
Mullis-Jannson S,
Sciacca R,
Wang J,
Burkhoff D,
Di Tullio MR,
and
Homma S.
Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach.
Am J Physiol Heart Circ Physiol
280:
H2364-H2370,
2001
20.
Tanaka, N,
Dalton N,
Mao L,
Rockman HA,
Peterson KL,
Gottshall KR,
Hunter JJ,
Chien KR,
and
Ross J, Jr.
Transthoracic echocardiography in models of cardiac disease in the mouse.
Circulation
94:
1109-1117,
1996
21.
Uechi, M,
Asai K,
Osaka M,
Smith A,
Sato N,
Wagner TE,
Ishikawa Y,
Hayakawa H,
Vatner DE,
Shannon RP,
Homcy CJ,
and
Vatner SF.
Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gs.
Circ Res
82:
416-423,
1998
22.
Vatner, SF,
and
Braunwald E.
Cardiovascular control mechanisms in the conscious state.
N Engl J Med
293:
970-976,
1975[ISI][Medline].
23.
Wallenstein, S,
Zucher CL,
and
Fleiss JL.
Some statistical methods useful in circulation research.
Circ Res
47:
1-9,
1980
24.
Winer, BJ.
Statistical Principles in Experimental Design (2nd ed.). New York: McGraw-Hill, 1971, p. 514-603.
25.
Wixson, SK,
and
Smiler KL.
Anesthesia and analgesia in rodents.
In: Anesthesia and Analgesia in Laboratory Animals, edited by Kohn DF,
Wixson SK,
White WJ,
and Benson GJ.. New York: Academic, 1997, p. 165-203.
26.
Yang, X,
Liu Y,
Rhaleb N,
Kurihara N,
Kim HE,
and
Carretero OA.
Echocardiographic assessment of cardiac function in conscious and anesthetized mice.
Am J Physiol Heart Circ Physiol
277:
H1967-H1974,
1999
27.
Zeller, W,
Meier G,
Burki K,
and
Panoussis B.
Adverse effects of tribromoethanol as used in the production of transgenic animals.
Lab Anim
32:
407-413,
1998
This article has been cited by other articles:
|
|
 |
|
  J. Dinkel, S. H. Bartling, J. Kuntz, M. Grasruck, A. Kopp-Schneider, M. Iwasaki, S. Dimmeler, R. Gupta, W. Semmler, H.-U. Kauczor, et al. Intrinsic Gating for Small-Animal Computed Tomography: A Robust ECG-Less Paradigm for Deriving Cardiac Phase Information and Functional Imaging Circ Cardiovasc Imaging, November 1, 2008; 1(3): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ahamed, N. Burg, K. Yoshinaga, C. A. Janczak, D. B. Rifkin, and B. S. Coller In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-{beta}1 Blood, November 1, 2008; 112(9): 3650 - 3660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Hinton Jr., C. M. Alfieri, S. A. Witt, B. J. Glascock, P. R. Khoury, D. W. Benson, and K. E. Yutzey Mouse heart valve structure and function: echocardiographic and morphometric analyses from the fetus through the aged adult Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2480 - H2488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mu, D. Qu, A. Bartczak, M. J. Phillips, J. Manuel, W. He, C. Koscik, M. Mendicino, L. Zhang, D. A. Clark, et al. Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice Physiol Genomics, September 11, 2007; 31(1): 53 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-A. S. Duhaney, L. Cui, M. K. Rude, N. K. Lebrasseur, S. Ngoy, D. S. De Silva, D. A. Siwik, R. Liao, and F. Sam Peroxisome Proliferator-Activated Receptor {alpha}-Independent Actions of Fenofibrate Exacerbates Left Ventricular Dilation and Fibrosis in Chronic Pressure Overload Hypertension, May 1, 2007; 49(5): 1084 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weytjens, B. Cosyns, J. D'hooge, C. Gallez, S. Droogmans, T. Lahoute, P. Franken, and G. Van Camp Doppler myocardial imaging in adult male rats: Reference values and reproducibility of velocity and deformation parameters Eur J Echocardiogr, December 1, 2006; 7(6): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Shin, C. D. Kamerath, J. F. Gilson, and J. K. Leypoldt Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2874 - 2880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jegger, X. Jeanrenaud, M. Nasratullah, P.-G. Chassot, A. Mallik, H. Tevaearai, L. K. von Segesser, P. Segers, and N. Stergiopulos Noninvasive Doppler-derived myocardial performance index in rats with myocardial infarction: validation and correlation by conductance catheter Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1540 - H1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yi, R. Bekeredjian, N. J. DeFilippis, Z. Siddiquee, E. Fernandez, and R. V. Shohet Transcriptional analysis of doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1098 - H1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Hacker, S. H. McKiernan, P. S. Douglas, J. Wanagat, and J. M. Aiken Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H304 - H311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schaefer, G. P. Meyer, D. Hilfiker-Kleiner, B. Brand, H. Drexler, and G. Klein Evaluation of Tissue Doppler Tei index for global left ventricular function in mice after myocardial infarction: Comparison with Pulsed Doppler Tei index Eur J Echocardiogr, October 1, 2005; 6(5): 367 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Lee, B.-H. Ko, J.-Y. Paik, K.-H. Jung, Y. S. Choe, Y. Choi, and B.-T. Kim Effects of Anesthetic Agents and Fasting Duration on 18F-FDG Biodistribution and Insulin Levels in Tumor-Bearing Mice J. Nucl. Med., September 1, 2005; 46(9): 1531 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liao, S. Takashima, N. Maeda, N. Ouchi, K. Komamura, I. Shimomura, M. Hori, Y. Matsuzawa, T. Funahashi, and M. Kitakaze Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism Cardiovasc Res, September 1, 2005; 67(4): 705 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barandon, P. Dufourcq, P. Costet, C. Moreau, C. Allieres, D. Daret, P. D. Santos, J.-M. D. Lamaziere, T. Couffinhal, and C. Duplaa Involvement of FrzA/sFRP-1 and the Wnt/Frizzled Pathway in Ischemic Preconditioning Circ. Res., June 24, 2005; 96(12): 1299 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Lindsey, D. K. Goshorn, C. E. Squires, G. P. Escobar, J. W. Hendrick, J. T. Mingoia, S. E. Sweterlitsch, and F. G. Spinale Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function Cardiovasc Res, May 1, 2005; 66(2): 410 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Karackattu, M. H. Picard, and M. Krieger Lymphocytes Are Not Required for the Rapid Onset of Coronary Heart Disease in Scavenger Receptor Class B Type I/Apolipoprotein E Double Knockout Mice Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barandon, T. Couffinhal, P. Dufourcq, P. Alzieu, D. Daret, C. Deville, and C. Duplaa Repair of Myocardial Infarction by Epicardial Deposition of Bone Marrow Cell-Coated Muscle Patch in a Murine Model Ann. Thorac. Surg., October 1, 2004; 78(4): 1409 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. A. Janssen, T. De Celle, J. J. M. Debets, A. E. Brouns, M. F. Callahan, and T. L. Smith Effects of anesthetics on systemic hemodynamics in mice Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1618 - H1624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Zemljic-Harpf, S. Ponrartana, R. T. Avalos, M. C. Jordan, K. P. Roos, N. D. Dalton, V. Q. Phan, E. D. Adamson, and R. S. Ross Heterozygous Inactivation of the Vinculin Gene Predisposes to Stress-Induced Cardiomyopathy Am. J. Pathol., September 1, 2004; 165(3): 1033 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ahn, J. Varagic, M. Slama, D. Susic, and E. D. Frohlich Cardiac structural and functional responses to salt loading in SHR Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H767 - H772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Morrison, R. J. Whittaker, R. E. Klepper, E. F. Wawrousek, and C. C. Glembotski Roles for {alpha}B-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H847 - H855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Wang, H. R. Brunner, and M. Burnier Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H806 - H814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Slama, J. Ahn, J. Varagic, D. Susic, and E. D. Frohlich Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H181 - H185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Garner, M. S. Willis, D. L. Carlson, J. M. DiMaio, M. D. White, D. J. White, G. A. Adams IV, J. W. Horton, and B. P. Giroir Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2500 - H2509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. A. Mammen, S. B. Kanatous, I. S. Yuhanna, P. W. Shaul, M. G. Garry, R. S. Balaban, and D. J. Garry Hypoxia-induced left ventricular dysfunction in myoglobin-deficient mice Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2132 - H2141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Okumura, J.-i. Kawabe, A. Yatani, G. Takagi, M.-C. Lee, C. Hong, J. Liu, I. Takagi, J. Sadoshima, D. E. Vatner, et al. Type 5 Adenylyl Cyclase Disruption Alters Not Only Sympathetic But Also Parasympathetic and Calcium-Mediated Cardiac Regulation Circ. Res., August 22, 2003; 93(4): 364 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Collins, C. E. Korcarz, and R. M. Lang Use of echocardiography for the phenotypic assessment of genetically altered mice Physiol Genomics, May 13, 2003; 13(3): 227 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Slama, D. Susic, J. Varagic, J. Ahn, and E. D. Frohlich Echocardiographic measurement of cardiac output in rats Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H691 - H697. [Abstract] [Full Text] [PDF]
|
|
| ||||||||
